软疣是一种具有高度传染性的常见病毒性皮肤病,主要感染对象为儿童等免疫力低下的人群。该疾病是由痘病毒引起的,可导致...查看全文
美股滚雪球2022-12-22 11:21
$Novan(NOVN)$ 表示,其子公司EPI Health已与佐藤制药(Sato Pharmaceutical)达成了一项在日本销售Rhofade护肤霜的许可协议。
Rhofade霜是一种处方药,用于治疗成年人因酒渣鼻引起的持续面部红肿。
根据协议,EPI Health将获得500万美元的预付款。EPI还将在日本获得市场批准时获得250万美元...查看全文
动脉网2022-12-04 08:11
近日,美国制药公司Novan在同行评审期刊JAMA Dermatology中发表了其用于治疗软疣的Berdazimer凝胶(10.3%)的3期研究结果。数据证明该药物具有良好的疗效和耐受性。如果获得批准,Berdazimer凝胶(10.3%)将会是FDA批准的第一个用于治疗这种病毒性皮肤感染的处方产品。
基于其独家一氧化氮(N...查看全文
产业链观察2022-07-14 00:14
药闻▶2022年7月13日,$Novan(NOVN)$ 今天宣布,其已完成的B-SIMPLE 4关键性3期临床研究的正面疗效和安全性数据已发表在同行评审期刊《美国医学会皮肤病学杂志》上,该研究评估了Berdazimer凝胶(10.3%),用于治疗软疣。
Berdazimer Sodium in Molluscum Patients with Lesions (B...查看全文
美股研究社2021-06-17 20:29
【美股盘前:股指期货齐跌 今晚关注初请数据】美股研究社讯,目前美股三大股指期货下挫,今晚将公布初请数据,市场预计初请失业金人数仍将继续减少,请投资者留意。盘面上,明星科技股下跌,抗疫概念股走高。个股方面,生物技术公司Novan(NOVN.O)盘前跌超18%,CureVac(CVAC.O)跌44%,$优信(UXIN)$ ...查看全文
智通财经APP获悉,6月14日(周一),Novan(NOVN.US)股价走高,截至北京时间23:30,该股涨超27%,报18.75美元。此前HC Wainwright & Co.上调公司目标价至28美元,该行维持Novan“买入”评级。 此前该公司宣布其抗病毒药物SB206在治疗接触... 网页链接
智通财经APP获悉,6月11日(周五),Novan(NOVN.US)股价走高,截至北京时间22:22,该股涨超97%,报17.81美元。公司宣布其抗病毒药物SB206在治疗接触传染性软疣的3期临床试验(B-SIMPLE4)主要终点上达到了统计学意义,并且没有报告严重不良... 网页链接
$Novan, Inc.(NOVN)$ 8-K - Current report Filed: 2017-11-06 AccNo: 0001564590-17-021825 Size: 48 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial S...
$Novan, Inc.(NOVN)$ 8-K - Current report Filed: 2017-10-23 AccNo: 0001564590-17-019733 Size: 12 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Novan, Inc.(NOVN)$ 8-K - Current report Filed: 2017-10-18 AccNo: 0001564590-17-019586 Size: 82 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Novan, Inc.(NOVN)$ EFFECT - Notice of Effectiveness Filed: 2017-10-10 AccNo: 9999999995-17-002632 Size: 1 KB 网页链接
$Novan, Inc.(NOVN)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-10-02 AccNo: 0001193125-17-301027 Size: 625 KB 网页链接
$Novan, Inc.(NOVN)$ 8-K - Current report Filed: 2017-09-27 AccNo: 0001564590-17-019015 Size: 36 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Novan, Inc.(NOVN)$ 8-K - Current report Filed: 2017-09-27 AccNo: 0001564590-17-019015 Size: 36 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Novan, Inc.(NOVN)$ 8-K - Current report Filed: 2017-09-27 AccNo: 0001564590-17-019015 Size: 36 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Novan, Inc.(NOVN)$ 内部交易: 2017-09-15,Interim Chief Financial Office,Hodges William L ,期权,5000普通股, $6.03
$Novan, Inc.(NOVN)$ 8-K - Current report Filed: 2017-08-18 AccNo: 0001564590-17-017817 Size: 36 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接